Monte Carlo characterization of target doses in stereotactic body radiation therapy (SBRT)

Premavathy Rassiah-Szegedi, Bill J. Salter, Clifton D. Fuller, Melissa Blough, Nikos Papanikolaou, Martin Fuss

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

To compare finite-size pencil beam/equivalent path-length (FSPB/EPL) and Monte Carlo (MC) SBRT dose computations for serial tomotherapy and to quantitatively assess dose differences between the dose calculation methods. Based on 72 SBRT plans for pulmonary targets, FSPB/EPL, considering the inhomogeneous lung environment, and MC calculations were performed to establish differences between FSPB/EPL predicted dose and MC derived doses. Compared with MC, FSPB/EPL consistently overestimated minimum doses to the clinical target volume and planning target volumes by an average of 18.1±7.15% (range 4 to 33.4%), and 21.9±10.4% (range 1.2 to 45.5%), respectively. The respective mean target dose differences were 15.5±7.4% (2.8-36.4%) and 19.2±7.6% (3.6-40.1%). Deviations from MC doses were lesion size and location dependent, with smaller lesions completely embedded into lung parenchyma being most susceptible. Larger lesion in contact with mediastinum and chest wall showed lesser differences. In comparison with MC dose calculation, FSPB/EPL overestimates doses delivered to pulmonary SBRT targets. The observed dose differences may have impact on local tumor control rates, and may deserve consideration when using fast, but less accurate dose calculation methods.

Original languageEnglish (US)
Pages (from-to)989-994
Number of pages6
JournalActa Oncologica
Volume45
Issue number7
DOIs
StatePublished - Sep 1 2006

Fingerprint

Radiotherapy
Lung
Mediastinum
Thoracic Wall
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Monte Carlo characterization of target doses in stereotactic body radiation therapy (SBRT). / Rassiah-Szegedi, Premavathy; Salter, Bill J.; Fuller, Clifton D.; Blough, Melissa; Papanikolaou, Nikos; Fuss, Martin.

In: Acta Oncologica, Vol. 45, No. 7, 01.09.2006, p. 989-994.

Research output: Contribution to journalArticle

Rassiah-Szegedi, Premavathy ; Salter, Bill J. ; Fuller, Clifton D. ; Blough, Melissa ; Papanikolaou, Nikos ; Fuss, Martin. / Monte Carlo characterization of target doses in stereotactic body radiation therapy (SBRT). In: Acta Oncologica. 2006 ; Vol. 45, No. 7. pp. 989-994.
@article{40c070e740c741c698a37abd9226475b,
title = "Monte Carlo characterization of target doses in stereotactic body radiation therapy (SBRT)",
abstract = "To compare finite-size pencil beam/equivalent path-length (FSPB/EPL) and Monte Carlo (MC) SBRT dose computations for serial tomotherapy and to quantitatively assess dose differences between the dose calculation methods. Based on 72 SBRT plans for pulmonary targets, FSPB/EPL, considering the inhomogeneous lung environment, and MC calculations were performed to establish differences between FSPB/EPL predicted dose and MC derived doses. Compared with MC, FSPB/EPL consistently overestimated minimum doses to the clinical target volume and planning target volumes by an average of 18.1±7.15{\%} (range 4 to 33.4{\%}), and 21.9±10.4{\%} (range 1.2 to 45.5{\%}), respectively. The respective mean target dose differences were 15.5±7.4{\%} (2.8-36.4{\%}) and 19.2±7.6{\%} (3.6-40.1{\%}). Deviations from MC doses were lesion size and location dependent, with smaller lesions completely embedded into lung parenchyma being most susceptible. Larger lesion in contact with mediastinum and chest wall showed lesser differences. In comparison with MC dose calculation, FSPB/EPL overestimates doses delivered to pulmonary SBRT targets. The observed dose differences may have impact on local tumor control rates, and may deserve consideration when using fast, but less accurate dose calculation methods.",
author = "Premavathy Rassiah-Szegedi and Salter, {Bill J.} and Fuller, {Clifton D.} and Melissa Blough and Nikos Papanikolaou and Martin Fuss",
year = "2006",
month = "9",
day = "1",
doi = "10.1080/02841860600919225",
language = "English (US)",
volume = "45",
pages = "989--994",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Monte Carlo characterization of target doses in stereotactic body radiation therapy (SBRT)

AU - Rassiah-Szegedi, Premavathy

AU - Salter, Bill J.

AU - Fuller, Clifton D.

AU - Blough, Melissa

AU - Papanikolaou, Nikos

AU - Fuss, Martin

PY - 2006/9/1

Y1 - 2006/9/1

N2 - To compare finite-size pencil beam/equivalent path-length (FSPB/EPL) and Monte Carlo (MC) SBRT dose computations for serial tomotherapy and to quantitatively assess dose differences between the dose calculation methods. Based on 72 SBRT plans for pulmonary targets, FSPB/EPL, considering the inhomogeneous lung environment, and MC calculations were performed to establish differences between FSPB/EPL predicted dose and MC derived doses. Compared with MC, FSPB/EPL consistently overestimated minimum doses to the clinical target volume and planning target volumes by an average of 18.1±7.15% (range 4 to 33.4%), and 21.9±10.4% (range 1.2 to 45.5%), respectively. The respective mean target dose differences were 15.5±7.4% (2.8-36.4%) and 19.2±7.6% (3.6-40.1%). Deviations from MC doses were lesion size and location dependent, with smaller lesions completely embedded into lung parenchyma being most susceptible. Larger lesion in contact with mediastinum and chest wall showed lesser differences. In comparison with MC dose calculation, FSPB/EPL overestimates doses delivered to pulmonary SBRT targets. The observed dose differences may have impact on local tumor control rates, and may deserve consideration when using fast, but less accurate dose calculation methods.

AB - To compare finite-size pencil beam/equivalent path-length (FSPB/EPL) and Monte Carlo (MC) SBRT dose computations for serial tomotherapy and to quantitatively assess dose differences between the dose calculation methods. Based on 72 SBRT plans for pulmonary targets, FSPB/EPL, considering the inhomogeneous lung environment, and MC calculations were performed to establish differences between FSPB/EPL predicted dose and MC derived doses. Compared with MC, FSPB/EPL consistently overestimated minimum doses to the clinical target volume and planning target volumes by an average of 18.1±7.15% (range 4 to 33.4%), and 21.9±10.4% (range 1.2 to 45.5%), respectively. The respective mean target dose differences were 15.5±7.4% (2.8-36.4%) and 19.2±7.6% (3.6-40.1%). Deviations from MC doses were lesion size and location dependent, with smaller lesions completely embedded into lung parenchyma being most susceptible. Larger lesion in contact with mediastinum and chest wall showed lesser differences. In comparison with MC dose calculation, FSPB/EPL overestimates doses delivered to pulmonary SBRT targets. The observed dose differences may have impact on local tumor control rates, and may deserve consideration when using fast, but less accurate dose calculation methods.

UR - http://www.scopus.com/inward/record.url?scp=33748869892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748869892&partnerID=8YFLogxK

U2 - 10.1080/02841860600919225

DO - 10.1080/02841860600919225

M3 - Article

C2 - 16982568

AN - SCOPUS:33748869892

VL - 45

SP - 989

EP - 994

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 7

ER -